Description
- INCLUSION:
- * Parent of a child diagnosed within the past month with acute lymphoblastic leukemia (ALL)
- * Pediatric patient's age 3 - 9.
- \* If present during the home visit, any other child, ages 0-18
- * Child on therapy that includes oral mercaptopurine (6-MP) administration
- * Parent age 18 - NA (No Limit)
- * Parent should have verbal English fluency
- * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
- * The following special populations may be included in this study:
- * Pregnant women: due to the design of this behavioral research, pregnant and fetuses should incur no elevated risk from participation.
- Children under age 18 will participate in one aspect of the study, the video recording of medication administration.
- \* Other children (not the pediatric patient) under age 18 that are present during the time of the home visit
- Exclusion:
- * Pediatric patient is on therapy that does not include oral 6-MP administration
- * Cognitively impaired adults/adults with impaired decision-making capacity
- * Pediatric patients who are not yet adults (infants under the age of 3, children over 9 years, teenagers)
- * Prisoners
Ages Eligible for Study:
18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
No